ABSTRACT NUMBER: ESOC2026A2031 PLASMA BIOMARKERS IN DELAYED CEREBRAL ISCHEMIA AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE

Abstract Background and aims An aneurysmal subarachnoid haemorrhage (aSAH) is a life-threatening neurovascular emergency. Among survivors of the initial insult, the most feared complication is Delayed Cerebral Ischemia (DCI), affecting approximately 30% of aSAH patients. Several mechanisms responsible for DCI development have been described. We have recently hypothesized that the endothelial glycocalyx plays a key role in these pathomechanisms. The aim of the current study is to assess whether glycocalyx breakdown precedes DCI following aSAH. Methods We prospectively obtained blood plasma samples during a two-week follow up period after aSAH diagnosis. We specifically evaluated Syndecan-1 and Hyaluronan levels, both are glycocalyx breakdown products, using commercially available ELISA kits. Results A total of 30 aSAH patients were included in this study, of which 7 developed DCI. Syndecan-1 as well as Hyaluronan showed a time-dependent increase between baseline measurement and two weeks post-ictus. This increase was more pronounced in in DCI patients compared to non-DCI patients. Conclusions Increased plasma concentrations of Syndecan-1 and Hyaluronan over two weeks post-ictus suggest that glycocalyx breakdown plays a role in aSAH and DCI development. This study needs extension and external validation to strengthen our results, and establish the potential of glycocalyx breakdown products as biomarkers for DCI. Conflict of interest K Aslankurt: nothing to declare, H Schenck: nothing to declare S van Kuijk: nothing to declare, E Gommer: nothing to declare, W Mess: nothing to declare, I de Ridder; nothing to declare, R van Lanen; nothing to declare, O Teernstra: nothing to declare, J Dings; nothing to declare, M Veldeman: nothing to declare, M Aries: nothing to declare, M Aries: nothing to declare, H Vink: is co-founder of the GlycoCalyx Research Institute and GlycoCheck, Y Temel: nothing to declare, R Haeren: nothing to declare

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1709
Primary Topic
Trauma, Hemostasis, Coagulopathy, Resuscitation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A2031 PLASMA BIOMARKERS IN DELAYED CEREBRAL ISCHEMIA AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE

Inger de Ridder, Yasin Temel, Hans Vink, Onno Teernstra et al.
European Stroke Journal
Trauma, Hemostasis, Coagulopathy, Resuscitation
article

ABSTRACT NUMBER: ESOC2026A2031 PLASMA BIOMARKERS IN DELAYED CEREBRAL ISCHEMIA AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE

Inger de Ridder, Yasin Temel, Hans Vink, Onno Teernstra, Sander van Kuijk, Marcel Aries, Michael Veldeman, Karmen Aslankurt, Jim Dings, Hanna Schenck, Rick Van Lanen, Erik Gommer, Roel Haeren
article en

Abstract

Abstract Background and aims An aneurysmal subarachnoid haemorrhage (aSAH) is a life-threatening neurovascular emergency. Among survivors of the initial insult, the most feared complication is Delayed Cerebral Ischemia (DCI), affecting approximately 30% of aSAH patients. Several mechanisms responsible for DCI development have been described. We have recently hypothesized that the endothelial glycocalyx plays a key role in these pathomechanisms. The aim of the current study is to assess whether glycocalyx breakdown precedes DCI following aSAH. Methods We prospectively obtained blood plasma samples during a two-week follow up period after aSAH diagnosis. We specifically evaluated Syndecan-1 and Hyaluronan levels, both are glycocalyx breakdown products, using commercially available ELISA kits. Results A total of 30 aSAH patients were included in this study, of which 7 developed DCI. Syndecan-1 as well as Hyaluronan showed a time-dependent increase between baseline measurement and two weeks post-ictus. This increase was more pronounced in in DCI patients compared to non-DCI patients. Conclusions Increased plasma concentrations of Syndecan-1 and Hyaluronan over two weeks post-ictus suggest that glycocalyx breakdown plays a role in aSAH and DCI development. This study needs extension and external validation to strengthen our results, and establish the potential of glycocalyx breakdown products as biomarkers for DCI. Conflict of interest K Aslankurt: nothing to declare, H Schenck: nothing to declare S van Kuijk: nothing to declare, E Gommer: nothing to declare, W Mess: nothing to declare, I de Ridder; nothing to declare, R van Lanen; nothing to declare, O Teernstra: nothing to declare, J Dings; nothing to declare, M Veldeman: nothing to declare, M Aries: nothing to declare, M Aries: nothing to declare, H Vink: is co-founder of the GlycoCalyx Research Institute and GlycoCheck, Y Temel: nothing to declare, R Haeren: nothing to declare

European Stroke JournalVol. 11(Supplement_1)
Maastricht University (NL), RWTH Aachen University (DE)
Openalex Percentile: Top 8%
Trauma, Hemostasis, Coagulopathy, Resuscitation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.